Conditions: Fetal Alcohol Syndrome Attention Deficit Hyperactivity Disorder (ADHD)
Keywords: fetal alcohol syndrome attention deficit disorder attention deficit disorder with hyperactivity ADD FAS FASD ADHD
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 27
Healthy volunteers: no

Brief summary:
Determine if atomoxetine is safe and well tolerated by children with fetal alcohol syndrome.

Detailed description:
Abnormalities of attention, function, and activity level in children exposed to alcohol in utero share similarities and differences to children who do not have alcohol exposure. Previous psychological studies have examined either core attention deficit hyperactivity (ADHD) symptoms of hyperactivity, inattention, and impulsivity or hypothesized neuropsychological differences in children with fetal alcohol syndrome (FAS) and ADHD. Atomoxetine Hydrochloride is a non-stimulant medication used to treat ADHD. This study will determine if atomoxetine HCL significantly reduces symptoms of ADD/ADHD in children with fetal alcohol exposure.

Arms:
arm 1: Teatment of children with fetal alcohol syndrome and ADHD with Atomoxetine HCL (Strattera)

Interventions: intervention 1: Atomoxetine
Intervention descriptions: intervention 1: Titrating with oral administration of 0.25 mg/kg, 0.50 mg/kg, 1.0 mg/kg, or 1.4 mg/kg once each morning with food.

Protocol document: